SCHEMBL1851665

SCHEMBL1851665

[N]c1cc(Cl)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31051471 0.78
SCHEMBL28153591 0.76 MEN1 (0.40)
Methylene Chloride SCHEMBL27947432 0.71 MEN1 (0.38)
SCHEMBL6128470 0.67
SCHEMBL858924 0.67
SCHEMBL18952494 0.67
Acetaldehyde SCHEMBL28232456 0.65 NPC1 (0.35)
Isopropyl Alcohol SCHEMBL28207243 0.65 NPC1 (0.35)
Hydrochloric Acid SCHEMBL11901592 0.65
SCHEMBL31426921 0.63 NPC1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150038516-A1 Inhibitors of Protein Kinases ASTRAZENECA AB (SE) 2015-02-05 US disclosed
US-8716296-B2 Inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2014-05-06 US disclosed
EP-2212297-B1 INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2011-05-25 EP disclosed
US-20100249149-A1 Inhibitors of Protein Kinases ASTRAZENECA AB (SE) 2010-09-30 US disclosed